This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23; On-demand experience Delivered September 28-30Boston Convention and Exhibition Center
Menu
Book Now
keyboard_arrow_right

DIGITAL - Sep. 29

search

DIGITAL - Sep. 29

search
On Demand
The TIDES 2021 Digital Agenda (Available for viewing from September 28, 2021) will consist of 100+ On-Demand Speaker Presentation Videos Recorded from the In-Person TIDES Boston conference PLUS A Scheduled Agenda of the Following Presentations taking place September 28-30.
    9:15am - 9:45am30 mins
    Liquid-phase Synthesis (LPS) of Oligonucleotide by Using Blockmer™
    • Ichiro Mori, PhD - Director of R&D, NATiAS Inc.
    10:00am - 10:30am30 mins
    Turning Tides Together. Manufacturing of Peptides and Oligonucleotides
    • Joseph Fraone - Business Development Manager, Oligonucleotides, Bachem
    10:45am - 11:15am30 mins
    Development, Optimization and Scale up of Therapeutic Peptides: Approaches to Solid Phase Synthesis
    • Colton Quick - Product Specialist, Gyros Protein Technologies
    11:30am - 12:00pm30 mins
    FEATURED LIVE PRESENTATION WITH LIVE Q&A: Clinical Development of Peptide Nucleic Acids: A First-in-Class Modality
    • Dietrich Stephan, Ph.D. - Chairman and CEO, NeuBase Therapeutics, Inc.
    12:00pm - 12:10pm10 mins
    Short Break
      12:10pm - 12:40pm30 mins
      Numaswitch - An Efficient Production Platform to Produce Peptides and Small Proteins
      • Christian Schwarz, PhD - CEO, Numaferm GmbH
      12:40pm - 12:45pm5 mins
      Short Break
        12:45pm - 1:15pm30 mins
        Optimizing Process Development for Biomolecule Purification
        • Hernan Alarcon, PhD - Research & Development Scientist, Agarose Bead Technologies
        • Jurgen Machielse - Director, Life Sciences, AIC
        1:30pm - 2:00pm30 mins
        Impurity Control Strategy - Liraglutide Case Study
        • Eran Benjamin, Ph.D. - Global Director, QC AD, PolyPeptide Group
        2:15pm - 2:45pm30 mins
        Use of Mustang® E Membrane Chromatography as Risk Mitigation for Endotoxin and Viral Clearance Contamination During UF/DF Processing
        • Robert Gronke, PhD - Senior Principal Scientist, Technical Development, Biogen, Inc
        • Sarah Blackmore - Viral Vector and Gene Therapy Technology Manager, Pall Biotech
        DIGITAL - Sep. 28
        NextDIGITAL - Sep. 30
        Choose Day